Myocardial T2* measurement is a valuable tool for non-invasive assessment of iron overload, and is clinically employed for planning and monitoring iron-chelating treatments for transfused thalassemia major patients [ 1 ]. Presently, for T2* assessment, dark-blood prepared gradient echo (GRE) images are acquired at multiple echo times (TEs). Thereafter, these images are analyzed within offline software such as CMRTools:ThalassaemiaTools®, in which the septal signal of a full thickness ROI is fitted to a monoexponential decay curve to estimate myocardial T2* [ 2 ]. The goal of this study was to develop and test a T2* measurement technique with automated inline T2*-map generation. Availability of such a technique on commercial MR systems may further utilization of such measurements in this patient group.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: